Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

2017/12/05 by Kayvon Modjarrad, Leyi Lin, Sarah L. George +59 · 2 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Immune responses and vaccinations #Mosquito-borne diseases and control #vaccines and immunoinformatics approaches

paper · doi:10.1016/s0140-6736(17)33106-9

openalex publication_date 2017/12/05 · crossref created 2017/12/05 · openalex created_date 2017/12/22 · crossref issued 2018/02/01 · crossref published 2018/02/01 · crossref published-print 2018/02/01 · crossref deposited 2025/09/26 · crossref indexed 2026/04/15 · openalex updated_date 2026/08/01

Cited by

• Zika virus vaccines
• Zika virus vaccine [wikipedia]